Mirador Capital Partners’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.79M | Buy |
|
|||||
|
2025
Q2 | $1.18M | Buy |
|
|||||
|
2025
Q1 | $832K | Buy |
|
|||||
|
2024
Q4 | $745K | Sell |
|
|||||
|
2024
Q3 | $1.4M | Sell |
|
|||||
|
2024
Q2 | $1.67M | Sell |
|
|||||
|
2024
Q1 | $1.2M | Sell |
|
|||||
|
2023
Q4 | $476K | Buy |
|
|||||
|
2023
Q3 | $104K | Sell |
|
|||||
|
2023
Q2 | $774K | Buy |
|
|||||
|
2023
Q1 | $960K | Buy |
|
|||||
|
2022
Q4 | $766K | Buy |
|
|||||
|
2022
Q3 | $557K | Sell |
|
|||||
|
2022
Q2 | $505K | Buy |
|
|||||
|
2022
Q1 | $625K | Buy |
|
|||||
|
2021
Q4 | $730K | Buy |
|
|||||
|
2021
Q3 | $510K | Buy |
|